ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $253,420 | -4.7% | 2,075 | -19.4% | 0.17% | -5.5% |
| Q3 2022 | $266,000 | +8.1% | 2,575 | -2.7% | 0.18% | +4.6% |
| Q2 2022 | $246,000 | -20.6% | 2,646 | +0.1% | 0.18% | -11.2% |
| Q1 2022 | $310,000 | -21.5% | 2,644 | -9.9% | 0.20% | -18.6% |
| Q4 2021 | $395,000 | +4.5% | 2,936 | +23.8% | 0.24% | -2.4% |
| Q3 2021 | $378,000 | +17.0% | 2,371 | -3.4% | 0.25% | +24.6% |
| Q2 2021 | $323,000 | -1.5% | 2,455 | -3.6% | 0.20% | -6.1% |
| Q1 2021 | $328,000 | -21.2% | 2,547 | +2.0% | 0.21% | -25.4% |
| Q4 2020 | $416,000 | +16.9% | 2,497 | +8.3% | 0.28% | -1.0% |
| Q3 2020 | $356,000 | +17.5% | 2,305 | +12.6% | 0.29% | +14.3% |
| Q2 2020 | $303,000 | – | 2,047 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |